Company
Lumenis
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
24
510(k), De Novo and PMA
Device trials
29
As lead sponsor, any status
Adverse event reports
1,239
Received Nov 1, 2025 to Nov 20, 2026
Recall records
16
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Lumenis, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Lumenis.
Latest FDA decisions
The 8 newest of 24 since 2015.
- SmartIPL_NI System510(k)
K241973 · Decided Sep 19, 2026 · 806 days after receipt
Device type: Powered Laser Surgical Instrument (GEX) · General & Plastic Surgery
- MILAN System510(k)
K253803 · Decided Jun 2, 2026 · 186 days after receipt
Device type: Electrosurgical, Cutting & Coagulation & Accessories (GEI) · General & Plastic Surgery
- Stellar M22510(k)
K250809 · Decided Apr 16, 2025 · 30 days after receipt
Device type: Powered Laser Surgical Instrument (GEX) · General & Plastic Surgery
21 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for ChalazionNot yet recruiting
NCT07405138 · 40 participants (planned) · Start Feb 4, 2026 · Primary completion Dec 2026
Device: Sham IPL; Active IPL · For: Chalazion
Sites: New York, New York; Seattle, Washington
NCT07039461 · 4 participants · Start Sep 12, 2025 · Primary completion Dec 24, 2025
Device: OptiLIGHT · For: Chalazion
Sites: New York, New York; Seattle, Washington
NCT06885112 · 40 participants (planned) · Start Feb 21, 2025 · Primary completion Feb 21, 2027
Device: FoLix treatment for improving the scalp hair appearance · For: Hair Loss
Sites: New York, New York
26 more trials with a free account
Reports received
1,239
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
1,129
91% of reports
Injury reports
110
8.9% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 51 | 9 | 0 | 0 |
| Jan 24 | 28 | 7 | 0 | 0 |
| Feb 24 | 43 | 2 | 0 | 0 |
| Mar 24 | 37 | 3 | 2 | 0 |
| Apr 24 | 52 | 4 | 0 | 0 |
| May 24 | 51 | 16 | 0 | 0 |
| Jun 24 | 76 | 32 | 0 | 0 |
| Jul 24 | 41 | 4 | 0 | 0 |
| Aug 24 | 63 | 9 | 0 | 0 |
| Sep 24 | 48 | 1 | 0 | 0 |
| Oct 24 | 57 | 8 | 0 | 0 |
| Nov 24 | 70 | 2 | 0 | 0 |
| Dec 24 | 67 | 6 | 0 | 0 |
| Jan 25 | 69 | 6 | 0 | 0 |
| Feb 25 | 104 | 10 | 0 | 0 |
| Mar 25 | 90 | 10 | 0 | 0 |
| Apr 25 | 78 | 11 | 0 | 0 |
| May 25 | 74 | 30 | 0 | 0 |
| Jun 25 | 84 | 39 | 1 | 0 |
| Jul 25 | 95 | 21 | 0 | 0 |
| Aug 25 | 97 | 10 | 0 | 0 |
| Sep 25 | 91 | 7 | 0 | 0 |
| Oct 25 | 93 | 9 | 0 | 0 |
| Nov 25 | 87 | 8 | 0 | 0 |
| Dec 25 | 102 | 6 | 0 | 0 |
| Jan 26 | 70 | 5 | 0 | 0 |
| Feb 26 | 90 | 6 | 0 | 0 |
| Mar 26 | 83 | 9 | 0 | 0 |
| Apr 26 | 83 | 15 | 0 | 0 |
| May 26 | 95 | 24 | 0 | 0 |
| Jun 26 | 108 | 9 | 0 | 0 |
| Jul 26 | 110 | 7 | 0 | 0 |
| Aug 26 | 90 | 5 | 0 | 0 |
| Sep 26 | 106 | 5 | 0 | 0 |
| Oct 26 | 105 | 11 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
- Moses Pulse170
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2344-2025 · Started Jul 22, 2025 · Posted by FDA Aug 21, 2025
Reason given: The potential for unsterilized product within finished product labeled as sterile.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Powered Laser Surgical Instrument (GEX)
Z-1290-2025 · Started Jan 23, 2025 · Posted by FDA Mar 5, 2025
Reason given: The initial current in certain chargers may lead to overheating and damage to the power resistors on the Alternating Current (AC) controller during the power-on sequence of the laser system, resulting in the laser system to not power on.
Cause as FDA categorized it: Under Investigation by firm · Device type: Powered Laser Surgical Instrument (GEX)
Z-0194-2022 · Started Oct 14, 2021 · Posted by FDA Nov 4, 2021
Reason given: Ultrasound gels and lotions manufactured by Eco-Med Pharmaceutical, Inc. may contain bacterial contamination. On August 18, 2021, FDA published a Letter to Health Care Providers to further address this issue:...
Cause as FDA categorized it: Process control · Device type: Transducer, Ultrasonic, Diagnostic (ITX)
13 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.